Mouse models of tuberous sclerosis complex

Danielle K Scheidenhelm1, David H Gutmann

  • 1Department of Neurology, Washington University School of Medicine, St Louis, MO 63110, USA.

Journal of Child Neurology
|November 26, 2004
PubMed

Insights

Tuberous sclerosis complex (TSC) involves brain and organ abnormalities due to TSC1/TSC2 gene mutations. Animal models are crucial for understanding TSC and developing future treatments for affected children.

Area of Science:

  • Genetics and Neuroscience
  • Developmental Biology
  • Medical Genetics

Background:

  • Tuberous sclerosis complex (TSC) is a genetic disorder with severe central nervous system (CNS) complications, including epilepsy, intellectual disability, autism, and glial tumors.
  • Mutations in TSC1 or TSC2 genes disrupt the hamartin-tuberin protein complex, leading to abnormal cell behavior and characteristic brain lesions (cortical tubers).

Purpose of the Study:

  • To investigate the cellular and molecular mechanisms underlying TSC pathogenesis.
  • To highlight the utility of animal models in studying TSC and developing therapeutic strategies.

Main Methods:

  • Utilized conventional and conditional knockout mouse models to study the functions of TSC1 (hamartin) and TSC2 (tuberin) genes.
  • Examined the impact of gene disruption on cellular differentiation, migration, and proliferation in the brain.

Main Results:

  • Demonstrated that TSC1/TSC2 gene mutations disrupt the hamartin-tuberin signaling complex.
  • Observed abnormal cellular processes in the brain, leading to the formation of cortical tubers, consistent with TSC pathology.

Conclusions:

  • Animal models are essential for understanding the diverse clinical manifestations of TSC.
  • These models hold significant promise as preclinical tools for developing targeted and effective treatments for TSC patients, particularly children.